Variant · Snv
CRY1 NM_004075.5(CRY1):c.1657+3A>C
CI-VAR-00068682Explore in graph →NM_004075.5:c.1657+3A>CClinVar 427574 rs184039278
Curated evidence
Evidence by cancer (0 items)
Grouped by cancer context first, then therapy. The same variant can be sensitizing in one cancer and irrelevant in another — contexts are never merged. 50 items per page; a cancer group may continue on the next page.
Data not yet available
No curated evidence item references this variant yet.
ClinVar
Clinical significance (1)
ClinVar interpretations are shown as structured records — significance, review status, star rating, conditions — never flattened into one word.
clinvarProvenance
- Source
- NCBI ClinVar (variant_summary)
- Dataset
- ClinVar variant_summary
- Version
- 2026-09-14
- Retrieved
- Sep 15, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Evidence
- database
- License
- Public domain (US Government work, NCBI/NLM); acknowledgment requested
- Run
- ING-CLINVAR-20260915-000001
| Variation | Clinical significance | Review status | Stars | Conditions | Origin | Submitters | Last evaluated | Source |
|---|---|---|---|---|---|---|---|---|
| 427574 | association; risk factor | no assertion criteria provided | 0 | Delayed sleep phase syndrome, susceptibility to; Attention deficit hyperactivity disorder; Sleep-wake schedule disorder, delayed phase type; Colorectal cancer; Gastric cancer; Nonpapillary renal cell carcinoma; Cervical cancer; Thymoma; Melanoma; Acute myeloid leukemia; Malignant tumor of urinary bladder; Uterine corpus endometrial carcinoma; Clear cell carcinoma of kidney; Colon adenocarcinoma; Sarcoma; Ovarian serous cystadenocarcinoma; Hepatocellular carcinoma; Lung cancer; Familial cancer of breast | germline | 3 | Jul 01, 2020 | clinvar |